{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:21:27Z","timestamp":1761060087272},"reference-count":28,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.3892\/ol.2016.4283","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T13:35:05Z","timestamp":1456407305000},"page":"2403-2407","source":"Crossref","is-referenced-by-count":3,"title":["An unresectable retroperitoneal malignant fibrous histiocytoma: A case report"],"prefix":"10.3892","volume":"11","author":[{"given":"PO-JEN","family":"HSIAO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUANG-HENG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YI-HUEI","family":"CHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHAO-HSIANG","family":"CHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAN","family":"CHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LI-YUAN","family":"BAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"key20180108094543_b1-ol-0-0-4283","first-page":"1161","article-title":"Malignant fibrous histiocytoma (pleomorphic undifferentiated sarcoma)","author":"Weiss","year":"2008","journal-title":"Enzinger and Weiss's Soft Tissue Tumors"},{"key":"key20180108094543_b2-ol-0-0-4283","article-title":"Malignant fibrous histiocytoma of the kidney treated with nephrectomy and adjuvant radiotherapy: A case report","volume":"802026","author":"Marchese","year":"2010","journal-title":"Case Rep Med 2010"},{"key":"key20180108094543_b3-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4291\/wjgp.v1.i5.171","article-title":"Retroperitoneal cystic lymphangioma in an adult: A case report and review of the literature","volume":"1","author":"Bhavsar","year":"2010","journal-title":"World J Gastrointest Pathophysiol"},{"key":"key20180108094543_b4-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/003655901753367668","article-title":"Malignant fibrous histiocytoma of the kidney","volume":"35","author":"Tarj\u00e1n","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"key20180108094543_b5-ol-0-0-4283","first-page":"1445","volume":"17","author":"O'Brien","year":"1964","journal-title":"Malignant fibrous xanthomas Cancer"},{"key":"key20180108094543_b6-ol-0-0-4283","first-page":"50","article-title":"Malignant fibrous histiocytoma of the liver: A case report and review of the literature","volume":"72","author":"Anagnostopoulos","year":"2005","journal-title":"Mt Sinai J Med"},{"key":"key20180108094543_b7-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2001.19.13.3203","article-title":"Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas","volume":"19","author":"Eilber","year":"2001","journal-title":"J Clin Oncol"},{"key":"key20180108094543_b8-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1245\/s10434-010-1156-3","article-title":"Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma","volume":"17","author":"Canter","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key20180108094543_b9-ol-0-0-4283","first-page":"3911","article-title":"Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma","volume":"32","author":"Shah","year":"2012","journal-title":"Anticancer Res"},{"key":"key20180108094543_b10-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.sla.0000108670.31446.54","article-title":"Operative management of primary retroperitoneal sarcomas: A reappraisal of an institutional experience","volume":"239","author":"Hassan","year":"2004","journal-title":"Ann Surg"},{"key":"key20180108094543_b11-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1477-7819-9-143","article-title":"Complete and safe resection of challenging retroperitoneal tumors: Anticipation of multi-organ and major vascular resection and use of adjunct procedures","volume":"9","author":"Tseng","year":"2011","journal-title":"World J Surg Oncol"},{"key":"key20180108094543_b12-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/1097-0142(19920415)69:8<2098::AID-CNCR2820690815>3.0.CO;2-9","article-title":"Prognostic factors in 277 patients with malignant fibrous histiocytoma","volume":"69","author":"Pezzi","year":"1992","journal-title":"Cancer"},{"key":"key20180108094543_b13-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10147-011-0360-x","article-title":"Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas","volume":"18","author":"Ogura","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"key20180108094543_b14-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jso.23520","article-title":"Assessment of multimodality therapy use for extremity sarcoma in the United States","volume":"109","author":"Sherman","year":"2014","journal-title":"J Surg Oncol"},{"key":"key20180108094543_b15-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1200\/JCO.2002.07.146","article-title":"Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas","volume":"20","author":"Wendtner","year":"2002","journal-title":"J Clinical Oncol"},{"key":"key20180108094543_b16-ol-0-0-4283","first-page":"133","article-title":"Neoadjuvant chemotherapy with ifosfamide, cisplatin, adriamycin and mitomycin (IMAP) for high risk adult soft tissue sarcomas","volume":"47","author":"Mohagheghi","year":"2009","journal-title":"Acta Med Iran"},{"key":"key20180108094543_b17-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-8140(02)00283-9","article-title":"Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma","volume":"65","author":"Gilbeau","year":"2002","journal-title":"Radiother Oncol"},{"key":"key20180108094543_b18-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cncr.23592","article-title":"A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma","volume":"113","author":"Pervaiz","year":"2008","journal-title":"Cancer"},{"key":"key20180108094543_b19-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1002\/cncr.26696","article-title":"Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas","volume":"118","author":"Mullen","year":"2012","journal-title":"Cancer"},{"key":"key20180108094543_b20-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1200\/JCO.1999.17.1.150","article-title":"Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens-a european organization for research and treatment of cancer soft tissue and bone sarcoma group study","volume":"17","author":"Van Glabbeke","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180108094543_b21-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/annonc\/mdr282","article-title":"High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: An open-label, randomized controlled trial","volume":"23","author":"Bui-Nguyen","year":"2012","journal-title":"Ann Oncol"},{"key":"key20180108094543_b22-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10637-008-9217-1","article-title":"Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma","volume":"27","author":"Fayette","year":"2009","journal-title":"Invest New Drugs"},{"key":"key20180108094543_b23-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejca.2012.08.007","article-title":"Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on pooled European organisation for research and treatment of cancer (EORTC) clinical trials 62771 and 62931","volume":"49","author":"Kasper","year":"2013","journal-title":"Eur J Cancer"},{"key":"key20180108094543_b24-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1989.7.9.1208","article-title":"Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy","volume":"7","author":"Elias","year":"1989","journal-title":"J Clin Oncol"},{"key":"key20180108094543_b25-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/3-540-30792-3_8","article-title":"Soft tissue tumours: The surgical pathologist's perspective","author":"Salgado","year":"2006","journal-title":"Imaging of Soft Tissue Tumors"},{"key":"key20180108094543_b26-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/annonc\/mdi082","article-title":"Prognostic factors in advanced synovial sarcoma: An analysis of 104 patients treated at the Royal Marsden Hospital","volume":"16","author":"Spurrell","year":"2005","journal-title":"Ann Oncol"},{"key":"key20180108094543_b27-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/cncr.23332","article-title":"Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: Retrospective analysis and identification of prognostic factors in 488 patients","volume":"112","author":"Karavasilis","year":"2008","journal-title":"Cancer"},{"key":"key20180108094543_b28-ol-0-0-4283","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.ejca.2005.07.023","article-title":"Differential sensitivity of liposarcoma subtypes to chemotherapy","volume":"41","author":"Jones","year":"2005","journal-title":"Eur J Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4283\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T11:21:57Z","timestamp":1515410517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,25]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,2,25]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.3892\/ol.2016.4283"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4283","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,25]]}}}